Compare CLGN & TSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLGN | TSE |
|---|---|---|
| Founded | 2004 | 2010 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.4M | 19.9M |
| IPO Year | N/A | 2014 |
| Metric | CLGN | TSE |
|---|---|---|
| Price | $1.85 | $0.49 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $11.50 | $1.00 |
| AVG Volume (30 Days) | 34.8K | ★ 1.3M |
| Earning Date | 11-26-2025 | 02-11-2026 |
| Dividend Yield | N/A | ★ 4.08% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $2,475,000.00 | ★ $3,133,800,000.00 |
| Revenue This Year | $1,596.12 | N/A |
| Revenue Next Year | $85.83 | $4.11 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 280.77 | N/A |
| 52 Week Low | $1.30 | $0.43 |
| 52 Week High | $4.98 | $5.99 |
| Indicator | CLGN | TSE |
|---|---|---|
| Relative Strength Index (RSI) | 64.68 | 40.76 |
| Support Level | $1.40 | $0.43 |
| Resistance Level | $1.99 | $0.95 |
| Average True Range (ATR) | 0.15 | 0.08 |
| MACD | 0.07 | -0.00 |
| Stochastic Oscillator | 93.22 | 12.00 |
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
Trinseo PLC is a materials company and manufacturer of latex and plastics products. The company's operating segments include Latex Binders, Americas Styrenics, Engineered Materials, and Polymer Solutions. Maximum revenue is generated from its Polymer Solutions segment, which consists of various polymers, the majority of which are for automotive, building, and construction applications. The product offerings of this segment include ABS, styrene-acrylonitrile, polystyrene, and polycarbonate products, which are marketed through brands like Magnum and Styron. Geographically, the company generates maximum revenue from Europe, followed by the United States, Asia-Pacific, and the Rest of the world.